azacitidine has been researched along with Erythrohepatic Protoporphyria in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fujiwara, S; Katayama, Y; Kawano, H; Matsui, T; Nakano, H; Nishigori, C; Taketani, S; Yoshioka, A | 1 |
| Edel, Y; Hodak, E; Kaftory, R; Lapidoth, M; Levi, A; Sherman, S; Snast, I | 1 |
| Kami, M; Kobayashi, K; Nishikawa, Y; Okuda, S; Takebayashi, C; Tanimoto, T | 1 |
1 review(s) available for azacitidine and Erythrohepatic Protoporphyria
| Article | Year |
|---|---|
Acquired erythropoietic protoporphyria: A systematic review of the literature.
Topics: Adult; Aged; Azacitidine; beta Carotene; Chromosomes, Human, Pair 18; Erythrocytes; Female; Ferrochelatase; Genetic Loci; Humans; Male; Middle Aged; Mutation; Myelodysplastic Syndromes; Photosensitivity Disorders; Protoporphyria, Erythropoietic; Protoporphyrins | 2020 |
2 other study(ies) available for azacitidine and Erythrohepatic Protoporphyria
| Article | Year |
|---|---|
Late-onset Erythropoietic Protoporphyria Associated with Myelodysplastic Syndrome Treated with Azacitidine.
Topics: Aged; Azacitidine; Disease Progression; Enzyme Inhibitors; Humans; Male; Myelodysplastic Syndromes; Protoporphyria, Erythropoietic; Skin; Treatment Outcome | 2018 |
A case of late onset erythropoietic protoporphyria associated with myelodysplastic syndrome treated by the combination of beta carotene and azacitidine.
Topics: Aged; Azacitidine; Benzoates; beta Carotene; Deferasirox; Humans; Male; Myelodysplastic Syndromes; Protoporphyria, Erythropoietic; Triazoles | 2013 |